Introduction
Optical biosensors are transforming how scientists identify and validate drug targets by delivering precise, real-time insights into molecular interactions. These techniques, including surface plasmon resonance (SPR), grating-coupled interferometry (GCI) and biolayer interferometry (BLI), have become essential for target-based drug discovery.
In this webinar, our expert speaker, Dr Florian Krieger, VP Biophysics at Evotec, will explore how optical biosensor techniques are being applied in real-world drug discovery pipelines. They will also dive into the latest technological advances and discuss future opportunities for these tools.
Key Insights
- The applications of optical biosensor techniques in drug discovery
- The advantages and current limitations of SPR, GCI and BLI
- How these tools may evolve in the future
- How to apply SPR, GCI and BLI to your drug discovery workflow
Speaker Bio
Dr Krieger holds a Diploma in Biochemistry from the University of Halle (2000) with a focus on enzymology and obtained his Ph.D. in Biophysical Chemistry from the University of Basel (2004) in the field of protein folding. He then spent three years as a postdoctoral fellow at Louis Pasteur University Strasbourg studying the modulation of nicotinic acetylcholine receptor by small molecules.
In 2008 he joined Evotec as a Research Scientist and became member of the he biochemical Assay Development group. Since this time, he gained experiences in small molecule HTS approaches but also contributed to the setup of Evotec’s biophysics platform. Since 2022 Dr Krieger is heading the biophysics unit at Evotec Hamburg site as VP Biophysics.
If the video has not loaded above, please click here.
